Cleared Traditional

K060061 - STRYKER INJECTABLE CEMENT

K060061 is an FDA 510(k) clearance for STRYKER INJECTABLE CEMENT, manufactured by Stryker Corp.. The device is a Class 2 Orthopedic device with product code MQV cleared through the Traditional 510(k) pathway after a 51-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2006
Decision
51d
Days
Class 2
Risk

K060061 is an FDA 510(k) clearance for the STRYKER INJECTABLE CEMENT. Classified as Filler, Bone Void, Calcium Compound (product code MQV), Class II - Special Controls.

Submitted by Stryker Corp. (Kalamazoo, US). The FDA issued a Cleared decision on March 1, 2006 after a review of 51 days - a notably fast clearance cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3045 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Stryker Corp. devices

FDA 510(k) Submission Details - K060061

510(k) Number K060061 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 09, 2006
Decision Date March 01, 2006
Days to Decision 51 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
71d faster than avg
Panel avg: 122d · This submission: 51d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MQV Device Classification - Class 2, Special Controls

Product Code MQV Filler, Bone Void, Calcium Compound
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3045
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - MQV Filler, Bone Void, Calcium Compound

All 407
Devices cleared under the same product code (MQV) and FDA review panel - the closest regulatory comparables to K060061.
COLLOSS E BONE VOID FILLER
K051047 · Ossacur AG · Mar 2006
NOVABONE PUTTY - RESORBABLE BONE VOID FILLER
K051617 · Novabone Products, LLC · Mar 2006
ALLOMATRIX CUSTOM
K053319 · Wrightmedicaltechnologyinc · Mar 2006
MIIG SR
K060011 · Wrightmedicaltechnologyinc · Feb 2006
THERIGRAFT TCP PUTTY BONE VOID FILLER
K053228 · Therics, LLC · Jan 2006
OSSIMEND (TM) BONE GRAFT MATERIAL
K052812 · Collagen Matrix, Inc. · Jan 2006